Latest Insider Transactions at Phreesia, Inc. (PHR)
This section provides a real-time view of insider transactions for Phreesia, Inc. (PHR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Phreesia, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Phreesia, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2023
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
266
+1.12%
|
$9,842
$37.49 P/Share
|
|
Jan 31
2023
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
266
+1.17%
|
$9,842
$37.49 P/Share
|
|
Jan 31
2023
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
266
+0.7%
|
$9,842
$37.49 P/Share
|
|
Jan 31
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
3,265
-3.0%
|
$124,070
$38.0 P/Share
|
|
Jan 30
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
28,555
-10.98%
|
$1,027,980
$36.07 P/Share
|
|
Jan 30
2023
|
Michael J. Davidoff SVP, Payer Business |
BUY
Exercise of conversion of derivative security
|
Direct |
12,090
+4.1%
|
$72,540
$6.37 P/Share
|
|
Jan 18
2023
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
649
-0.5%
|
$23,364
$36.07 P/Share
|
|
Jan 17
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
2,324
-1.82%
|
$81,340
$35.0 P/Share
|
|
Jan 17
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,008
-1.0%
|
$35,280
$35.0 P/Share
|
|
Jan 17
2023
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,233
-0.31%
|
$78,155
$35.0 P/Share
|
|
Jan 17
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
964
-0.44%
|
$33,740
$35.0 P/Share
|
|
Jan 17
2023
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55,346
-4.36%
|
$1,937,110
$35.0 P/Share
|
|
Jan 15
2023
|
Michael J. Davidoff SVP, Payer Business |
BUY
Grant, award, or other acquisition
|
Direct |
31,770
+19.94%
|
-
|
|
Jan 15
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
9,107
-4.41%
|
$318,745
$35.41 P/Share
|
|
Jan 15
2023
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
19,768
+16.4%
|
-
|
|
Jan 15
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
5,352
-3.13%
|
$187,320
$35.41 P/Share
|
|
Jan 15
2023
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,184
+5.85%
|
-
|
|
Jan 15
2023
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,812
-1.42%
|
$693,420
$35.41 P/Share
|
|
Jan 15
2023
|
Randy Rasmussen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,184
+23.11%
|
-
|
|
Jan 15
2023
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,868
-1.75%
|
$65,380
$35.41 P/Share
|
|
Jan 15
2023
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
45,184
+17.18%
|
-
|
|
Jan 15
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
11,246
-3.09%
|
$393,610
$35.41 P/Share
|
|
Jan 15
2023
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
31,064
+19.27%
|
-
|
|
Jan 15
2023
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,124
-2.1%
|
$74,340
$35.41 P/Share
|
|
Jan 15
2023
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,601
+5.26%
|
-
|
|
Jan 15
2023
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,193
-1.51%
|
$1,301,755
$35.41 P/Share
|
|
Jan 14
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
1,239
-1.17%
|
$43,365
$35.41 P/Share
|
|
Jan 14
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
698
-0.8%
|
$24,430
$35.41 P/Share
|
|
Jan 14
2023
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,816
-0.26%
|
$63,560
$35.41 P/Share
|
|
Jan 14
2023
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,496
-1.38%
|
$52,360
$35.41 P/Share
|
|
Jan 14
2023
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
1,592
-0.86%
|
$55,720
$35.41 P/Share
|
|
Jan 14
2023
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,288
-1.26%
|
$45,080
$35.41 P/Share
|
|
Jan 14
2023
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,288
-0.27%
|
$115,080
$35.41 P/Share
|
|
Jan 03
2023
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.47%
|
$320,000
$32.22 P/Share
|
|
Dec 31
2022
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
242
+0.24%
|
$5,082
$21.63 P/Share
|
|
Dec 20
2022
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
378
-0.43%
|
$12,474
$33.73 P/Share
|
|
Dec 20
2022
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+14.64%
|
$0
$0.84 P/Share
|
|
Dec 17
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
15
-0.27%
|
$495
$33.97 P/Share
|
|
Dec 16
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
36
-0.64%
|
$1,188
$33.97 P/Share
|
|
Dec 14
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
801
-0.78%
|
$28,836
$36.0 P/Share
|
|
Dec 13
2022
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
11,377
-5.78%
|
$386,818
$34.61 P/Share
|
|
Dec 13
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
3,109
-2.93%
|
$105,706
$34.4 P/Share
|
|
Dec 12
2022
|
Randy Rasmussen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,395
-6.38%
|
$229,245
$31.77 P/Share
|
|
Dec 09
2022
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
26,837
-12.0%
|
$778,273
$29.77 P/Share
|
|
Dec 09
2022
|
Randy Rasmussen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,934
-3.99%
|
$298,020
$30.79 P/Share
|
|
Nov 06
2022
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,636
-4.29%
|
$135,264
$24.34 P/Share
|
|
Nov 02
2022
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
19,341
-7.46%
|
$522,207
$27.18 P/Share
|
|
Oct 31
2022
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
366
+1.56%
|
$9,882
$27.32 P/Share
|
|
Oct 31
2022
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
366
+0.97%
|
$9,882
$27.32 P/Share
|
|
Oct 31
2022
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
366
+1.62%
|
$9,882
$27.32 P/Share
|